ARTICLE | Clinical News
BB-882 PAF antagonist: Started Phase II Trial
March 29, 1993 8:00 AM UTC
British Bio-technology Group plc. (BBIOY) Product: BB-882 PAF antagonist Indication: Acute pancreatitis Status: Started Phase II Trial in the United Kingdom. ...